These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 32006600)
1. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts. Nofal A; Yehia E; Khater E; Bessar H J Am Acad Dermatol; 2020 Jul; 83(1):208-210. PubMed ID: 32006600 [No Abstract] [Full Text] [Related]
2. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts. Kim KH; Horn TD; Pharis J; Kincannon J; Jones R; O'Bryan K; Myers J; Nakagawa M Arch Dermatol; 2010 Dec; 146(12):1431-3. PubMed ID: 21173332 [No Abstract] [Full Text] [Related]
3. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional Nofal A; El-Arab RE; Nasr M; Alakad R J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654 [TBL] [Abstract][Full Text] [Related]
4. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Horn TD; Johnson SM; Helm RM; Roberson PK Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380 [TBL] [Abstract][Full Text] [Related]
6. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts. Nofal A; Alakad R; Fouda I; Fawzy MM J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211 [TBL] [Abstract][Full Text] [Related]
7. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts. Marei A; Nofal A; Alakad R; Abdel-Hady A J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869 [TBL] [Abstract][Full Text] [Related]
8. Intralesional Candida antigen for common warts in people with HIV. Wong A; Crawford RI J Cutan Med Surg; 2013; 17(5):313-5. PubMed ID: 24067850 [TBL] [Abstract][Full Text] [Related]
9. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Johnson SM; Roberson PK; Horn TD Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925 [TBL] [Abstract][Full Text] [Related]
10. Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children. Muñoz Garza FZ; Roé Crespo E; Torres Pradilla M; Aguilera Peirò P; Baltà Cruz S; Hernández Ruiz ME; Baselga Torres E Pediatr Dermatol; 2015; 32(6):797-801. PubMed ID: 26584692 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Intralesional Zayan H; Hosny AH; Mamdouh MM; Tawfik YM J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287 [TBL] [Abstract][Full Text] [Related]
17. Intralesional immunotherapy for genital warts. King M; Johnson SM; Horn TD Arch Dermatol; 2005 Dec; 141(12):1606-7. PubMed ID: 16365274 [No Abstract] [Full Text] [Related]
18. Intralesional Candida antigen versus intralesional tuberculin in the treatment of recalcitrant genital warts: A comparative study. Nofal A; Soliman M; Hamdy F; Alakad R J Am Acad Dermatol; 2020 Jun; 82(6):1512-1514. PubMed ID: 31923442 [No Abstract] [Full Text] [Related]
19. Role of mannose binding lectin in response to candida antigen immunotherapy of warts. Nasr M; Marie A; Boghdadi G; Elsaid R; Salah E J Dermatolog Treat; 2021 Jun; 32(4):376-380. PubMed ID: 31469597 [TBL] [Abstract][Full Text] [Related]
20. Treatment of recalcitrant verruca vulgaris with Candida antigen in patient with human immunodeficiency virus. Summers P; Richards-Altmon P; Halder R J Drugs Dermatol; 2009 Mar; 8(3):268-9. PubMed ID: 19271374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]